Dr. Sara Misthal, MD

Dr. Misthal practices at Hospital of the University of Pennsylvania - Cedar Avenue in Philadelphia, Pennsylvania.

Dr. Misthal's NPI, 1194138164, was assigned on June 8, 2014. Dr. Misthal holds Pennsylvania license MD461761.

Dr. Misthal's primary practice is Hospital of the University of Pennsylvania - Cedar Avenue, at 501 S 54th St, Philadelphia, PA 19143 in Philadelphia County. The practice phone is (215) 762-0888.

Dr. Misthal's primary practice is Hospital of the University of Pennsylvania - Cedar Avenue in Philadelphia, Pennsylvania. Dr. Misthal is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Misthal to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Misthal practices, 2 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Misthal's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Misthal is licensed in Pennsylvania.

CMS data shows 98 Medicare services from Dr. Misthal across 3 procedure codes in 2024, for 101 Medicare patients. Medicare paid $10,835 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 101 Medicare patients who saw Dr. Misthal in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Misthal's median patient age at 43, with 55% women.

In 2024, Dr. Misthal wrote 53 Medicare Part D claims for 27 patients. 89% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $342 in total drug cost. In 2023, CMS named 34 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Misthal for performance year 2024, reported as part of a group. Dr. Misthal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Misthal from 2 drug and device companies from 2017 to 2021. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $115.